- Home
- SHOT vs SGMO Comparison
SHOT vs SGMO Comparison
Compare SHOT & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHOT
- SGMO
- Stock Information
- Founded
- SHOT 2018
- SGMO 1995
- Country
- SHOT United States
- SGMO United States
- Employees
- SHOT N/A
- SGMO N/A
- Industry
- SHOT Biotechnology: Pharmaceutical Preparations
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SHOT Health Care
- SGMO Health Care
- Exchange
- SHOT Nasdaq
- SGMO Nasdaq
- Market Cap
- SHOT 137.3M
- SGMO 122.8M
- IPO Year
- SHOT 2020
- SGMO 2000
- Fundamental
- Price
- SHOT $0.40
- SGMO $0.53
- Analyst Decision
- SHOT
- SGMO Strong Buy
- Analyst Count
- SHOT 0
- SGMO 7
- Target Price
- SHOT N/A
- SGMO $5.29
- AVG Volume (30 Days)
- SHOT 8.3M
- SGMO 5.2M
- Earning Date
- SHOT 08-14-2025
- SGMO 08-07-2025
- Dividend Yield
- SHOT N/A
- SGMO N/A
- EPS Growth
- SHOT N/A
- SGMO N/A
- EPS
- SHOT N/A
- SGMO N/A
- Revenue
- SHOT N/A
- SGMO $81,706,000.00
- Revenue This Year
- SHOT N/A
- SGMO $21.24
- Revenue Next Year
- SHOT N/A
- SGMO N/A
- P/E Ratio
- SHOT N/A
- SGMO N/A
- Revenue Growth
- SHOT 246.36
- SGMO 565.52
- 52 Week Low
- SHOT $0.23
- SGMO $0.41
- 52 Week High
- SHOT $1.77
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- SHOT 40.49
- SGMO 47.38
- Support Level
- SHOT $0.38
- SGMO $0.47
- Resistance Level
- SHOT $0.46
- SGMO $0.56
- Average True Range (ATR)
- SHOT 0.05
- SGMO 0.04
- MACD
- SHOT -0.01
- SGMO -0.00
- Stochastic Oscillator
- SHOT 8.19
- SGMO 42.31
About SHOT Safety Shot Inc.
Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.